Catalyst Funds Management Pty LTD United Therapeutics Corp Transaction History
Catalyst Funds Management Pty LTD
- $455 Billion
- Q3 2024
A detailed history of Catalyst Funds Management Pty LTD transactions in United Therapeutics Corp stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 300 shares of UTHR stock, worth $113,907. This represents 0.02% of its overall portfolio holdings.
Number of Shares
300Holding current value
$113,907% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding UTHR
# of Institutions
672Shares Held
42.4MCall Options Held
194KPut Options Held
295K-
Black Rock Inc. New York, NY5.47MShares$2.08 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.41MShares$1.67 Billion0.03% of portfolio
-
Wellington Management Group LLP Boston, MA3.17MShares$1.2 Billion0.2% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.86MShares$1.09 Billion15.42% of portfolio
-
State Street Corp Boston, MA2.24MShares$850 Million0.03% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $17.3B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...